Using Gilteritinib to Keep People With Acute Myeloid Leukemia Cancer-free After a Stem Cell Transplant
Clinical trial NCT06734585 · COMPLETED
Trial details
- NCT number
- NCT06734585
- Sponsor
- Astellas Pharma Singapore Pte. Ltd.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2025-01-09
- Primary completion
- 2025-07-14
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.